Drug Discovery

Five ways machine learning can power life science data analysis

• May 23, 2023

Intellegens announces Alchemite™ Academic Programme

• March 28, 2023

Focus Group shares new case studies and examples

• December 14, 2022

Press Release: Alchemite™ 2022 Autumn Release

• September 29, 2022

Knowledge from noise – new algorithm turns uncertainty into a positive

• September 21, 2022

Didn’t we do this already? More value from R&D knowledge

• August 30, 2022

Predicting pharmacokinetics with Optibrium and AstraZeneca

• April 11, 2022

Alchemite™ powered deep learning with “small data”

• February 1, 2022

Alchemite™ identifies potential antimalarial drug

• November 17, 2021

Alchemite™ validated for global pharma data in peer-reviewed study

• June 29, 2021

Optimising kinase profiling programs with Optibrium and Genentech

• June 2, 2021

Innovate UK Funded Project Produces Next-Generation AI Drug Discovery Platform

• December 3, 2020